FDMT vs PODD · rev $37.0K vs P/E 34, rev $2.07B
4D Molecular Therapeutics Inc (FDMT) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
FDMT currently screens at market cap $518.1M. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the FDMT and PODD stock pages for the full models.
Not investment advice.